Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2010 2
2011 6
2012 2
2013 1
2014 2
2016 2
2017 4
2018 3
2020 5
2021 3
2022 2
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

31 results

Results by year

Filters applied: . Clear all
Page 1
Immunological consequences of cladribine treatment in multiple sclerosis: A real-world study.
Rolfes L, Pfeuffer S, Huntemann N, Schmidt M, Su C, Skuljec J, Aslan D, Hackert J, Kleinschnitz K, Hagenacker T, Pawlitzki M, Ruck T, Kleinschnitz C, Meuth SG, Pul R. Rolfes L, et al. Among authors: skuljec j. Mult Scler Relat Disord. 2022 Aug;64:103931. doi: 10.1016/j.msard.2022.103931. Epub 2022 May 29. Mult Scler Relat Disord. 2022. PMID: 35690010 Free article.
Anti-EBNA1 IgG titre is not associated with fatigue in multiple sclerosis patients.
Fleischer M, Schuh H, Bickmann NM, Hagenacker T, Krüger K, Skripuletz T, Fiedler M, Kleinschnitz C, Pul R, Skuljec J. Fleischer M, et al. Among authors: skuljec j. Neurol Neurochir Pol. 2022;56(3):236-245. doi: 10.5603/PJNNS.a2022.0043. Epub 2022 Jun 21. Neurol Neurochir Pol. 2022. PMID: 35726751 Free article.
Autoimmune glomerulonephritis in a multiple sclerosis patient after cladribine treatment.
Schönfelder K, Schuh H, Pfister F, Krämer J, Eisenberger U, Skuljec J, Hackert J, Ruck T, Pfeuffer S, Fleischer M, Gäckler A, Hagenacker T, Kribben A, Meuth SG, Kleinschnitz C, Pul R. Schönfelder K, et al. Among authors: skuljec j. Mult Scler. 2021 Oct;27(12):1960-1964. doi: 10.1177/13524585211022719. Epub 2021 Jun 24. Mult Scler. 2021. PMID: 34165361 Free PMC article.
FoxP3 deficiency causes no inflammation or neurodegeneration in the murine brain.
Gingele S, Pul R, Sardari M, Borbor M, Henkel F, Moellenkamp TM, Gudi V, Happle C, Grychtol R, Habener A, Hansen G, Hermann DM, Stangel M, Kleinschnitz C, Skuljec J. Gingele S, et al. Among authors: skuljec j. J Neuroimmunol. 2020 Mar 18;342:577216. doi: 10.1016/j.jneuroim.2020.577216. Online ahead of print. J Neuroimmunol. 2020. PMID: 32199198
Gain-of-function STAT1 mutations are associated with intracranial aneurysms.
Dadak M, Jacobs R, Skuljec J, Jirmo AC, Yildiz Ö, Donnerstag F, Baerlecken NT, Schmidt RE, Lanfermann H, Skripuletz T, Schwenkenbecher P, Kleinschnitz C, Tumani H, Stangel M, Pul R. Dadak M, et al. Among authors: skuljec j. Clin Immunol. 2017 May;178:79-85. doi: 10.1016/j.clim.2017.01.012. Epub 2017 Feb 2. Clin Immunol. 2017. PMID: 28161409
CCL5 induces a pro-inflammatory profile in microglia in vitro.
Skuljec J, Sun H, Pul R, Bénardais K, Ragancokova D, Moharregh-Khiabani D, Kotsiari A, Trebst C, Stangel M. Skuljec J, et al. Cell Immunol. 2011;270(2):164-71. doi: 10.1016/j.cellimm.2011.05.001. Epub 2011 May 26. Cell Immunol. 2011. PMID: 21620385
31 results